NIAGEN BIOSCIENCE, INC. Unamortized Debt Issuance Expense
NIAGEN BIOSCIENCE, INC. (NAGE) had Unamortized Debt Issuance Expense of $47.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:UnamortizedDebtIssuanceExpense · last filed 2026-03-04
- 2025-12-31: Unamortized Debt Issuance Expense $47.00K.
- 2024-12-31: Unamortized Debt Issuance Expense $39.00K.
- 2023-12-31: Unamortized Debt Issuance Expense $68.00K.
- 2022-12-31: Unamortized Debt Issuance Expense $69.00K.
| Period end | Unamortized Debt Issuance Expense | Unamortized Debt Issuance Expense as first filed |
|---|---|---|
| 2025-12-31 | $47.00K 10-K · filed 2026-03-04 | |
| 2024-12-31 | $39.00K 10-K · filed 2026-03-04 | |
| 2023-12-31 | $68.00K 10-K · filed 2025-03-04 | |
| 2022-12-31 | $69.00K 10-K · filed 2024-03-06 | |
| 2021-12-31 | $59.00K 10-K · filed 2022-03-14 | |
| 2020-12-31 | $57.00K 10-K · filed 2021-03-12 | |
| 2019-12-31 | $100.00K 10-K · filed 2020-03-10 | |
| 2018-12-31 | $65.00K 10-K · filed 2019-03-07 | |
| 2018-06-30 | $65.00K 10-Q · filed 2018-08-09 | |
| 2017-12-30 | $115.00K 10-K · filed 2018-03-15 | |
| 2016-12-31 | $161.00K 10-K · filed 2017-03-16 | |
| 2016-01-02 | $65.00K 10-K · filed 2016-03-17 | |
| 2015-10-03 | $75.26K 10-Q · filed 2015-11-12 | |
| 2015-07-04 | $85.16K 10-Q · filed 2015-08-13 | |
| 2015-04-04 | $80.45K 10-Q · filed 2015-05-14 | |
| 2015-01-03 | $91.00K 10-K · filed 2016-03-17 | $91.36K 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |